Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study

J Am Acad Dermatol. 2024 May;90(5):1031-1034. doi: 10.1016/j.jaad.2024.01.004. Epub 2024 Jan 9.
No abstract available

Keywords: JAK inhibitors; acne; acneiform eruption; atopic dermatitis; side effects; upadacitinib.

Publication types

  • Multicenter Study

MeSH terms

  • Acne Vulgaris* / drug therapy
  • Dermatitis, Atopic* / drug therapy
  • Heterocyclic Compounds, 3-Ring*
  • Humans
  • Janus Kinase Inhibitors* / adverse effects
  • Retrospective Studies
  • Treatment Outcome

Substances

  • upadacitinib
  • Janus Kinase Inhibitors
  • Heterocyclic Compounds, 3-Ring